Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search span> per specialist: Antoine ADENIS, MD, PhD
Woman and Man Max 99 years
Antoine ADENIS, MD, PhD
Update Il y a 5 ans
Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
The purpose of this study is to determine the maximum tolerated dose of imatinib mesylate, given in association with a fixed dose of cyclophosphamide (50 mg bid).
Country
France
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antoine ADENIS, MD, PhD
Update Il y a 5 ans
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer
Country
France
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antoine ADENIS, MD, PhD
Update Il y a 5 ans
Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases
This study describes the elevation of CPK in patient treated for solid tumors by TKI
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antoine ADENIS, MD, PhD
Update Il y a 5 ans
Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer
Interest of continuing systemic chemotherapy or not , after a short initial treatment (6 weeks) in patients who are in response or stable disease("Discontinuation design ")of patients with...
Country
None
organs
None
Specialty
None
Closed trial
More information